Literature DB >> 18821172

Pulmonary hypertension in primary biliary cirrhosis: a prospective study in 178 patients.

Min Shen1, Fengchun Zhang, Xuan Zhang.   

Abstract

UNLABELLED: OBJECTIVE. To analyze the incidence, clinical features, and prognosis of patients with primary biliary cirrhosis (PBC) complicated by pulmonary hypertension (PH).
MATERIAL AND METHODS: A total of 178 consecutive PBC patients, who were admitted to Peking Union Medical College Hospital from January 2001 to March 2007, were included in this prospective study. A structured interview, systemic rheumatological examination, laboratory tests (including autoantibodies), and Doppler echocardiography were conducted for each patient and compared between patients with and without PH.
RESULTS: Twenty-one PBC patients (11.8%) had PH. Among them, four patients (19.0%) had moderate to severe PH, and one patient died of right heart failure instead of liver failure. The incidences of Raynaud's phenomenon, interstitial lung disease, Sjögren's syndrome, and portal hypertension, the proportion of patients with a positive anti-SSA, the level of serum IgA, as well as the Mayo risk score in the PH-PBC patients were significantly higher than in the non-PH-PBC group (p = 0.02, 0.001, 0.02, 0.03, 0.006, 0.04 and 0.02, respectively).
CONCLUSIONS: PH, including moderate to severe PH, is not a rare complication of PBC. This complication is closely associated with portal hypertension and immunological dysregulation and indicates a poor prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 18821172     DOI: 10.1080/00365520802400883

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Reduced thoracic fluid content in early-stage primary biliary cirrhosis that associates with impaired cardiac inotropy.

Authors:  Pawel Zalewski; David Jones; Ieuan Lewis; James Frith; Julia L Newton
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-18       Impact factor: 4.052

2.  Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study.

Authors:  Li Wang; Feng-Chun Zhang; Hua Chen; Xuan Zhang; Dong Xu; Yong-Zhe Li; Qian Wang; Li-Xia Gao; Yun-Jiao Yang; Fang Kong; Ke Wang
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

Review 3.  Pulmonary Manifestations among Patients with Primary Biliary Cirrhosis.

Authors:  Deniz Koksal; Aydin Seref Koksal; Ahmet Gurakar
Journal:  J Clin Transl Hepatol       Date:  2016-08-14

4.  Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy.

Authors:  Tetsuro Yokokawa; Akiomi Yoshihisa; Tomofumi Misaka; Takamasa Sato; Takashi Kaneshiro; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Yasuchika Takeishi
Journal:  Intern Med       Date:  2021-01-15       Impact factor: 1.271

5.  CXCL12-CXCR4-Mediated Chemotaxis Supports Accumulation of Mucosal-Associated Invariant T Cells Into the Liver of Patients With PBC.

Authors:  Zhilei Chen; Suying Liu; Chengmei He; Jinlei Sun; Li Wang; Hua Chen; Fengchun Zhang
Journal:  Front Immunol       Date:  2021-03-19       Impact factor: 7.561

Review 6.  Recent advances in the diagnosis and treatment of primary biliary cholangitis.

Authors:  Ying-Qiu Huang
Journal:  World J Hepatol       Date:  2016-11-28

7.  Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.

Authors:  Sainan Bian; Hua Chen; Li Wang; Yunyun Fei; Yunjiao Yang; Linyi Peng; Yongzhe Li; Fengchun Zhang
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.